SUMMARY IgM rheumatoid factor was assayed by three routine methods: latex fixation; haemagglutination; and end point laser nephelometry in 69 patients with definite or classical rheumatoid arthritis and 58 patients with other non-rheumatoid arthropathies, selected prospectively according to the American Rheumatism Association clinical criteria. The operators of the assays were unaware of the clinical diagnoses. In the group with rheumatoid arthritis 75-4% were positive by latex fixation, 73*9% by haemagglutination, and 55 1% by nephelometry. In the group with nonrheumatoid arthropathies 10-4% were positive by latex fixation, 8-6% by haemagglutination, and 10-4% by nephelometry. Thus the simple and inexpensive latex fixation test was as good as the haemagglutination test, and both were significantly better than nephelometry in the laboratory confirmation of the clinical diagnosis of definite or classic rheumatoid arthritis (X2 = 5.40 and 4 56, and p < 0 025 and < 0 05, respectively). None of these tests was significantly better or worse than the others in producing positive results in the group with non-rheumatoid arthropathies.
The variable and inadequate specificity and sensitivity of these variations on the same technique are well known.5 6 Laser nephelometry has begun to be used more in the routine measurement of plasma proteins, including IgM rheumatoid factor.78 This technique depends on the formation of antigen-antibody Accepted for publication 21 August 1986 complexes, which scatter a beam of light in proportion to the concentration of the antibody in the test serum. Several studies on the detection of serum IgM rheumatoid factor have now been published, in which it is claimed that laser nephelometry may be equal or superior to the older agglutination techniques in several respects, including sensitivity and specificity. [9] [10] [11] [12] As the clinical context of these studies is not always clear, however, we conducted a prospective comparative study of laser nephelometry v two agglutination techniques (latex fixation and haemagglutination) to detect IgM rheumatoid factor in patients who had been selected prospectively on clinical grounds only and not on the basis of previous serological results where these were available.
Material and methods Sera were obtained from 69 patients with definite or classic rheumatoid arthritis and 58 patients with nonrheumatoid arthropathy or soft tissue rheumatism. The study was prospective, and any previous serological results were not considered when the patients were selected. The clinical diagnosis was unknown to
Comparison of laser nephelometry and standard agglutination techniques the operators of the assays. All sera were stored at -20'C and thawed before assay at room temperature. All reagents used were of analytical grade. Tables 1 to 5 show the results. There were no significant differences between the patients with rheumatoid arthritis and those with non-rheumatoid arthropathies in distribution of ages (table 2) . Table 3 shows that in the group with rheumatoid arthritis 75-4% of sera were positive by latex fixation, 73-9% by haemagglutination, and 55-1% by nephelometry. In the group with non-rheumatoid arthropathies 10-4% of sera were positive by latex fixation, 8-6% by haemagglutination, and 10X4% by nephelometry. group with non-rheumatoid arthropathies there were no significant differences when each test was compared with the other two in the same way. Table 5 shows that in the group with rheumatoid arthritis positivity for IgM rheumatoid factor increased with age and that the lower rate ofdetection by the nephelopmetric assay persisted throughout the age groups. In the group with rheumatoid arthritis there were three discrepant results between the latex fixation and haemagglutination assays, and in all three nephelometric assay was negative. In the group with non-rheumatoid arthropathies only one patient gave a discrepant result between latex fixation and haemagglutination.
Discussion
Enthusiastic reports of the value of nephelometric assays of IgM rheumatoid factor have recently been published.9'-2 It has been suggested that this technique has specificity and sensitivity equal to or greater than the established assays based on particle agglutination. The results obtained in this study do not confirm this. The latex fixation and haemagglutination assays had equivalent sensitivity and specificity, which were greater than those of the nephelometric assay. This was surprising and requires explanation. One explanation may be that this is the first study in which assays of IgM rheumatoid factor have been compared prospectively and blindly in patients who were defined strictly according to ARA clinical criteria alone.1 It is also the largest prospective study of this sort to have been done.
In a comparative study9 of 92 patients with a variety of joint disorders, 72 of whom had rheumatoid arthritis, nephelometry was found to be as accurate an assay of IgM rheumatoid factor as the differential agglutination test (DAT). In the group with rheumatoid arthritis, however, both assays had detection rates of 61%, which is similar to the nephelometric rate in this report (55-1%), but all are unacceptably low rates compared with a DAT detection rate of 77% obtained in one series of 1102 tests. '7 In another study'0 assays of IgM rheumatoid factor by latex fixation and nephelometric techniques were compared in 100 consecutive patients admitted to a geriatric unit. Only three had rheumatoid arthritis-two with radiological lesions but no clinical activity. Eighty nine patients gave negative results by both assays, which suggests a high degree of concordance, but the authors concluded that the latex slide test had a 9% incidence of false positive results compared with a 2% incidence using nephelometry. When the results from our study are broken down into age groups and the ratio of positive:negative results is obtained, then the nephelometric assay consistently scores a much lower positive rate for all age groups, and in the patients over 60 years of age fails to achieve the ratio obtained by the latex fixation and haemagglutination assays in the patients aged 50 to 59 years. This lower sensitivity may explain why a lower false positive rate was obtained with a nephelometric assay in the study of geriatric patients.'0 It is unlikely that the difference in the false positive rates between the latex fixation and nephelometric assays carried any statistical significance in that study.
Two further studies, both retrospective, concluded that the nephelometric assay was equal to other techniques.1 '2 In the first of these " sera were assayed for IgM rheumatoid factor retrospectively from 30 patients with classic or definite rheumatoid arthritis and 23 healthy controls. Good correlation between a radioimmunoassay and a nephelometric assay was obtained (r = 0-97, p < 0-001), but sensitivity and specificity were not reported. In the second study'2 a rate nephelometric assay was compared with a latex fixation assay and an R-W assay in sera from 100 patients with rheumatoid arthritis, 70 with nonrheumatoid arthropathies, and 50 blood donors. Comparable sensitivities were obtained, although the nephelometric assay was less specific than the others. The detection rates were high (nephelometry 80%, latex fixation 83%, R-W 75%) in the group with rheumatoid arthritis compared with 70% for a latex fixation assay in a much larger study, (Lloyd KN, et al. Abstract, XIV International Congress of Rheumatology, San Francisco, 1981), and they suggest a bias in selection of sera in such a retrospective study.
Superficially, use of rate nephelometry seems to give greater sensitivity to the IgM rheumatoid factor assay than an end point technique, if the results of the study by Roberts-Thomson et al'2 are compared with those of Pritchard and Jobbins.9 It has been shown in another recent study, '7 however, that rate nephelometry produces a detection rate in patients with rheumatoid arthritis in line with that found in our study. The R-W, latex fixation rate nephelometry and enzyme linked immunosorbant (ELISA) assays of IgM rheumatoid factor were compared in 48 patients with rheumatoid arthritis and 48 blood donors. In the group with rheumatoid arthritis the positive rates Prentice, Hickling, Wiseman, Holwill, Northwood were 60%, 90%, 69%, and 92%, respectively. That study was not described as prospective or blind, or of patients selected by clinical criteria alone. Therefore the comparatively high latex fixation and ELISA results suggest that sera may have been preselected by another method or that only classic and no definite patients with rheumatoid arthritis were studied. The difference between the detection rate in the latex fixation assay and that of the nephelometric assay, however, was comparable to that reported here. Rate nephelometry does not consistently improve the sensitivity of the nephelometric assay.
Although the methodologies of latex fixation and nephelometry were comparable in all the studies reviewed, including the present study, the cellular agglutination assays were varied. It is unlikely that this variability of techniques explains the variable results in these studies, however, as the results obtained with diverse cellular agglutination techniques have been shown to be comparable in this study and in a previous study.'0 In summary, it seems that there are sufficient grounds for not accepting either end point or rate laser nephelometry as equal to or better than any other technique used to detect serum IgM rheumatoid factor. This is particularly true in view of the results presented in this study, where the assays were used as screening tests to confirm clinical diagnoses based on ARA criteria. Nephelometric assays may have a place in quantitation of IgM rheumatoid factor in patients already known to be seropositive,'2 17 although the superior sensitivity of the ELISA method suggests that it may be preferable for quantitation.17
